Ann: Appointment of Dr Howie McKibbon as CEO, page-111

Just a formality , most of the Pharma Manufacturers meet stringent Manufacturing Processes , GMP etc ...

But remember ,, the FDA are the watchdog and would be held accountable for accrediting a Treatment that was not fit for purpose..

IMHO , with no snags to date and with lessons learnt BOT will be dotting i's and crossing t's keeping their eye on the prize...

The actual Science is in "Proven" imagine that's the cake completed ,,, FDA approval is Icing on top and Cream filling with shaved Truffles and a glass of Krug on the side...

I am truly amazed at the churn of 18, 18.5, 19, shares???
Lowering Volume does signify , slightly tighter hands but as the clock ticks away on FDA approval , further risk is reduced.. Ironically now 2 weeks of 18,19.5 fluctuations relates to Two Weeks of further FDA processing,, so closer to the finish line and a significant rerate..